Abstract
Rutin, a glycoside of flavonol, inhibits osteoclast formation induced by receptor activator of NF-kappaB ligand (RANKL) in bone marrow-derived macrophages. It reduces reactive oxygen species produced by RANKL and its inhibitory effect results from reduced levels of TNF-alpha. Rutin also lowers NF-kappaB activation in response to RANKL.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Mice
-
Mice, Inbred C57BL
-
NF-kappa B / metabolism*
-
Osteoclasts / cytology*
-
Osteoclasts / drug effects*
-
RANK Ligand / pharmacology
-
Reactive Oxygen Species / metabolism*
-
Rutin / pharmacology*
-
Tumor Necrosis Factor-alpha / metabolism*
-
Tumor Necrosis Factor-alpha / pharmacology
Substances
-
NF-kappa B
-
RANK Ligand
-
Reactive Oxygen Species
-
Tumor Necrosis Factor-alpha
-
Rutin